Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunologic enhancement with intermittent interleukin-2 therapy

Immunologic enhancement with intermittent interleukin-2 therapy

US Patent 5696079 · Granted Dec 9, 1997

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of antagonists of the interaction between HIV GP120 and α4β7 integrin2018
Use of antagonists of the interaction between HIV GP120 and α4β7 integrin2016
Use of antagonists of the interaction between HIV GP120 and A4B7 integrin2015
Fusion protein including of CD42008
HIV related peptides2005
Identification of a region of the major surface glycoprotein (MSG) gene of human2003
Immunologic enhancement with intermittent interleukin-2 therapy2003
Immunologic enhancement with intermittent interleukin-2 therapy2003
Immunologic enhancement with intermittent interleukin-2 therapy2003
Immunologic enhancement with intermittent interleukin-2 therapy2001
Immunologic enhancement with intermittent interleukin-2 therapy2001
Immunologic enhancement with intermittent interleukin-2 therapy2001